Cargando…
A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of blindness for the elderly in high-income countries. Although multivitamin antioxidant nutrients can slow the progression of intermediate “dry” or nonneovascular AMD, no treatment can halt or reverse any stage of dry disease. Multiple bio...
Autores principales: | Abidi, Muhammad, Karrer, Erik, Csaky, Karl, Handa, James T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767821/ https://www.ncbi.nlm.nih.gov/pubmed/36570624 http://dx.doi.org/10.1016/j.xops.2022.100213 |
Ejemplares similares
-
Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022) -
Update on Clinical Trials in Dry Age-related Macular Degeneration
por: Taskintuna, Ibrahim, et al.
Publicado: (2016) -
The Relationship Between Central Drusen Volume and Low-Luminance Deficit in Age-Related Macular Degeneration
por: Ou, William C., et al.
Publicado: (2020) -
Correlation between hyperreflective foci and visual function testing in eyes with intermediate age-related macular degeneration
por: Liu, T. Y. Alvin, et al.
Publicado: (2023) -
A profile of circulating vascular progenitor cells in human neovascular age-related macular degeneration
por: Catchpole, Timothy, et al.
Publicado: (2020)